21 C.F.R. § 556.226

Enrofloxacin.

Last amended: 2021Year: 2026Length: 76 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 556.226 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residue of enrofloxacin is 3 µg/kg of body weight per day. (b) Tolerances. The tolerances for enrofloxacin are: (1) Cattle. Liver (target tissue): 0.1 ppm desethylene ciprofloxacin (marker residue). (2) Swine. Liver (target tissue): 0.5 ppm enrofloxacin (marker residue). (c) Related conditions of use. See §§ 516.812 and 522.812 of this chapter. [84 FR 32993, July 11, 2019, as amended at 86 FR 13188, Mar. 8, 2021]
Cross-references to the CFR
516.812
21 C.F.R. § 556.226: Enrofloxacin. | Justis AI